Abstract
Plasma interleukin-8 (IL-8), interleukin-10 (IL-10), and E-selectin concentrations were studied in 39 neutropenic and 30 non-neutropenic bacteremic patients; 54 nonbacteremic patients were analyzed as controls. Interleukin-8 concentrations were significantly higher in neutropenic than in non-neutropenic bacteremic patients (median 475 vs. 0 pg/ml, p<0.0001). Median IL-8 and IL-10 levels were higher in bacteremic than in non-bacteremic patients (330 vs. 0 pg/ml, p<0.0001 and 20 vs. 0 pg/ml, p=0.04, respectively). In contrast, concentrations of IL-10 were similar in neutropenic and non-neutropenic patients. Median levels of E-selectin were not increased in any of the patient groups. Neutropenic bacteremic patients showed significantly lower concentrations of E-selectin than did non-neutropenic bacteremic patients (p<0.0001). In conclusion, neutropenic bacteremic patients had significantly higher concentrations of IL-8 than non-neutropenic bacteremic patients. Levels of IL-10 were higher in bacteremic than in nonbacteremic patients, but neutropenic and non-neutropenic patients had similar levels of IL-10. Increased levels of E-selectin were not found in any of the patient groups, although neutropenic patients with bacteremia had lower concentrations than did non-neutropenic patients.
Similar content being viewed by others
References
Glauser MP, Heumann D, Baumgartner JD, Cohen J: Pathogenesis and potential strategies for prevention and treatment of septic shock: an update. Clinical Infectious Diseases 1994, 18, Supplement 2: 205–216.
Lawrence MB, Springer TA: Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 1991, 64: 1–20.
Phillips ML, Nudelman E, Gaeta FCA, Perez M, Singhal AK, Hakomori S, Paulson JC: ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science 1990, 250: 1130–1132.
Baggiolini M, Walz A, Kunkel SL: Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. Journal of Clinical Investigation 1989, 84: 1045–1049.
Van Zee KJ, DeForge LE, Fischer E, Marano M, Kenney JS, Remick DG, Lowry S, Moldawer LL: IL-8 in septic shock, endotoxemia and after IL-1 administration. Journal of Immunology 1991, 146: 3478–3482.
Hubere AR, Kunkel SL, Todd RF III, Weiss SJ: Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 1991, 254: 99–102.
Marty C, Misset B, Tamion F, Fitting C, Carlet J, Cavailon J-M: Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Critical Care Medicine 1994, 22: 673–679.
Hack CE, Hart M, Strack van Schijndel RJM, Eerenberg AJM, Nuijens JH, Thijs LG, Aarden LA: Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infection and Immunity 1992, 60: 2835–2842.
Hynninen M, Valtonen M, Vaara M, Markkanen H, Kuusela R, Saxen H, Takkunen O: Endotoxin and cytokine concentrations in neutropenic and non-neutropenic bacteremic patients. European Journal of Clinical Microbiology & Infectious Diseases 1996, 14: 1039–1045.
Fiorentino DF, Zlotnik A, Mosmann TR: IL-10 inhibits cytokine production by activated macrophages. Journal of Immunology 1991, 147: 3815–3822.
Howard M, Muchamel T, Andrade S: lnterleukin-10 protects mice from lethal endotoxemia. Journal of Experimental Medicine 1993, 177: 547–550.
Marchant A, Deviere J, Byl B, De Groote D, Vincent J-L, Goldman M: lnterleukin-10 production during septicaemia. Lancet 1994, 343: 707–708.
Derkx B, Marchant A, Goldman M, Bijlmer R, van Deventer S: High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. Journal of Infectious Diseases 1995, 171: 229–232.
Newman W, Beall LD, Carson CW, Hunder CG, Graben N, Randshawa ZI, Gopal TV, Wiener-Kronish J, Marhay MA: Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. Journal of Immunology 1993, 150: 644–654.
Adams DH, Shaw S: Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 1994, 343: 830–836.
Kuhns DB, Alvord WG, Gallin JI: Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans. Journal of Infectious Diseases 1995, 171: 145–152.
Boldt J, Mueller M, Kuhn D, Linke LC, Hempelmann G: Circulating adhesion molecules in the critically ill: a comparison between trauma and sepsis patients. Intensive Care Medicine 1996, 22: 122–128.
Cowley HC, Heney D, Gearing AJH, Hemingway I, Webster NR: Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: a prospective cohort study. Critical Care Medicine 1994, 22: 651–657.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hynninen, M., Valtonen, M., Vaara, M. et al. Plasma interleukin-8, interleukin-10, and E-selectin levels in neutropenic and non-neutropenic bacteremic patients. Eur. J. Clin. Microbiol. Infect. Dis. 16, 587–591 (1997). https://doi.org/10.1007/BF02447921
Issue Date:
DOI: https://doi.org/10.1007/BF02447921